Leverone Jason A. Insider Trades & Stock Holdings

Chief Financial Officer · OnKure Therapeutics, Inc. · Latest filing Sep 21, 2026

Leverone Jason A., Chief Financial Officer at OnKure Therapeutics, Inc. has 1 Form 4 trade on file since Sep 21, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($898.21), net -$898.21. Latest filing: disposed of 302 shares of $OKUR on Sep 21, 2026 at $2.97.

Trades on file

1

Open-market bought

$0

Open-market sold

$898.21

Net open-market

-$898.21

Latest filing

Sep 21, 2026

All insider trades by Leverone Jason A.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 21, 2026	$OKUR	Sell (Open-market sale)	302	$2.97	$898.21						Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Leverone Jason A. traded

• $OKUR

Frequently asked questions

Has Leverone Jason A. been buying or selling stock?

Leverone Jason A. has 0 open-market purchases and 1 open-market sale on file, net -$898.21. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Leverone Jason A.'s latest insider trade?

disposed of 302 shares of $OKUR on Sep 21, 2026 at $2.97.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.